{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:44:34Z","timestamp":1793504674638,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"French Health Ministry","award":["PHRCI-17-087"],"award-info":[{"award-number":["PHRCI-17-087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Brain metastases often occur in cancer evolution. They are not only responsible for death but also for disorders affecting the quality of life and the cognitive functions.<\/jats:p>\n<jats:p>Management of brain metastases usually consists in multi-modality treatments, including neurosurgery, whole brain radiotherapy (WBRT), and more recently radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSRT), systemic treatment (chemotherapy or targeted therapy), combined or not with corticosteroids. Almost 20% of brain metastases can present recent (within 15\u2009days) bleeding signs on neuro-imagery. In these conditions, WBRT is the usual treatment. Yet, patients may benefit from a more aggressive strategy with SRT or FSRT. However, these options were suspected to possibly major the risk of brain haemorrhage, although no scientifically proven. Radiation oncologists therefore usually remain reluctant to deliver SRS\/FSRT for bleeding brain metastases.<\/jats:p>\n<jats:p>It is therefore challenging to establish a standard of care for the treatment of bleeding brain metastases.<\/jats:p>\n<jats:p>We propose a phase II trial to simultaneously assess safety and efficacy of FSRT to manage brain metastases with hemorrhagic signal.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The STEREO-HBM study is a multicenter two-step non-randomised phase II trial addressing patients with at least one bleeding brain metastasis out of a maximum of 3 brain metastases. Each brain metastasis will be treated with 30\u2009Gy in 3 fractions for 1 week.<\/jats:p>\n<jats:p>The main endpoint is based on both safety and efficacy endpoints as proposed by Bryant and Day\u2019s design. Safety endpoint is defined as the rate of bleeding complications 4\u2009months post-FSRT while efficacy endpoint is defined as the 6-month local control rate. Multi-modal MRI will be used to assess intra-tumoral hemorrhagic events before and after treatment. Patients\u2019 quality of life will also be assessed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>Management of bleeding brain metastases is still debated and poorly explored in clinical trials. There is sparse and weak data on the signification of pretreatment intra-tumour haemorrhagic signs or on the risk of brain bleeding complications after FSRT.<\/jats:p>\n<jats:p>We expect this first prospective phase 2 trial in this particular setting will allow to clarify the place of FSRT to optimally manage bleeding brain metastases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/results?term=03696680&amp;Search=Search\">NCT 03696680<\/jats:ext-link>, registered October, 4, 2018.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Protocol version<\/jats:title>\n<jats:p>Version 2.1 dated from 2018\/11\/09.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-6569-1","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T15:02:47Z","timestamp":1582383767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Paul","family":"Lesueur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Leconte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Geffrelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Lequesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Brachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Hrab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Clarisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinu","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,22]]},"reference":[{"key":"6569_CR1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00415-002-0870-6","volume":"249","author":"R Soffietti","year":"2002","unstructured":"Soffietti R, Rud\u0101 R, Mutani R. Management of brain metastases. J Neurol. 2002;249:1357\u201369.","journal-title":"J Neurol"},{"key":"6569_CR2","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/1097-0142(19840601)53:11<2550::AID-CNCR2820531129>3.0.CO;2-B","volume":"53","author":"S Madajewicz","year":"1984","unstructured":"Madajewicz S, Karakousis C, West CR, Caracandas J, Avellanosa AM. Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer. 1984;53:2550\u20132.","journal-title":"Cancer"},{"key":"6569_CR3","first-page":"47","volume":"4","author":"JB Posner","year":"1974","unstructured":"Posner JB. Diagnosis and treatment of metastases to the brain. Clin Bull. 1974;4:47\u201357.","journal-title":"Clin Bull"},{"key":"6569_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0360-3016(80)90195-9","volume":"6","author":"B Borgelt","year":"1980","unstructured":"Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, et al. The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys. 1980;6:1\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6569_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","volume":"88","author":"JH Sampson","year":"1998","unstructured":"Sampson JH, Carter JH, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88:11\u201320.","journal-title":"J Neurosurg"},{"key":"6569_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1227\/00006123-198204000-00004","volume":"10","author":"S Wakai","year":"1982","unstructured":"Wakai S, Yamakawa K, Manaka S, Takakura K. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery. 1982;10:437\u201344.","journal-title":"Neurosurgery"},{"key":"6569_CR7","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3171\/jns.1987.67.6.0852","volume":"67","author":"D Kondziolka","year":"1987","unstructured":"Kondziolka D, Bernstein M, Resch L, Tator CH, Fleming JF, Vanderlinden RG, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg. 1987;67:852\u20137.","journal-title":"J Neurosurg"},{"key":"6569_CR8","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295:2483\u201391.","journal-title":"JAMA"},{"key":"6569_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/1471-2407-10-582","volume":"10","author":"T Meyners","year":"2010","unstructured":"Meyners T, Heisterkamp C, Kueter J-D, Veninga T, Stalpers LJA, Schild SE, et al. Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis. BMC Cancer. 2010;10:582.","journal-title":"BMC Cancer"},{"key":"6569_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/jnnp.74.7.908","volume":"74","author":"H Suzuki","year":"2003","unstructured":"Suzuki H. Spontaneous haemorrhage into metastatic brain tumours after stereotactic radiosurgery using a linear accelerator. J Neurol Neurosurg Psychiatry. 2003;74:908\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl","key":"6569_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3171\/JNS\/2008\/109\/12\/S16","volume":"109","author":"AJ Redmond","year":"2008","unstructured":"Redmond AJ, Diluna ML, Hebert R, Moliterno JA, Desai R, Knisely JPS, et al. Gamma knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival. J Neurosurg. 2008;109(Suppl):99\u2013105.","journal-title":"J Neurosurg"},{"key":"6569_CR12","doi-asserted-by":"crossref","unstructured":"Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, Kirkwood J, Lunsford LD. Gamma knife radiosurgery for malignant melanoma brain metastases. Clin Neurosurg. 2007;54:241\u20137","DOI":"10.1227\/01.NEU.0000255342.10780.52"},{"issue":"4","key":"6569_CR13","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.2307\/2533268","volume":"51","author":"J Bryant","year":"1995","unstructured":"Bryant J, Day R. Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics. 1995;51(4):1372\u201383.","journal-title":"Biometrics"},{"issue":"5","key":"6569_CR14","first-page":"936","volume":"56","author":"EL Chang","year":"2005","unstructured":"Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A, Sawaya R, Woo SY. Outcome variation among \u201cradioresistant\u201d brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005;56(5):936\u201345.","journal-title":"Neurosurgery"},{"key":"6569_CR15","doi-asserted-by":"crossref","unstructured":"Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, Kirkwood J, Lunsford LD. Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery. 2007;60(3):471-81; discussion 481\u20132.","DOI":"10.1227\/01.NEU.0000255342.10780.52"},{"issue":"3","key":"6569_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(14)71106-4","volume":"16","author":"Arjun Sahgal","year":"2015","unstructured":"Sahgal A, Larson D, Knisely J. Stereotactic radiosurgery alone for brain metastases. Lancet Oncol. 2015;16(3):249\u201350. https:\/\/doi.org\/10.1016\/S1470-2045(14)71106-4.","journal-title":"The Lancet Oncology"},{"issue":"4","key":"6569_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","volume":"15","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014;15(4):387\u201395.","journal-title":"Lancet Oncol"},{"issue":"6","key":"6569_CR18","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1177\/147323000903700620","volume":"37","author":"J Zhang","year":"2009","unstructured":"Zhang J, Zhang ZB, Gao H, Zhang D, Wang WL. Haemorrhage detection in brain metastases of lung cancer patients using magnetic resonance imaging. Int Med Res. 2009;37(6):1842\u201350.","journal-title":"Int Med Res"},{"issue":"2","key":"6569_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11060-014-1519-x","volume":"119","author":"R Wiggenraad","year":"2014","unstructured":"Wiggenraad R, Bos P, Verbeek-de Kanter A, Lycklama \u00c0, Nijeholt G, van Santvoort J, Taphoorn M, Struikmans H. Pseudo-progression after stereotactic radiotherapy of brain metastases: lesion analysis using MRI cine-loops. J Neuro-Oncol. 2014;119(2):437\u201343.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"6569_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305. Int J Radiat Oncol Biol Phys. 2000;47(2):291\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"6569_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0167-8140(03)00207-X","volume":"68","author":"G No\u00ebl","year":"2003","unstructured":"No\u00ebl G, Simon JM, Valery CA, Cornu P, Boisserie G, Hasboun D, Ledu D, Tep B, Delattre JY, Marsault C, Baillet F, Mazeron JJ. Radiosurgery for brain metastasis: impact of CTV on local control. Radiother Oncol. 2003;68(1):15\u201321.","journal-title":"Radiother Oncol"},{"issue":"1","key":"6569_CR22","first-page":"140","volume":"52","author":"SD Chang","year":"2003","unstructured":"Chang SD, Main W, Martin DP, Gibbs IC, Heilbrun MP. An analysis of the accuracy of the CyberKnife: a robotic frameless stereotactic radiosurgical system. Neurosurgery. 2003;52(1):140\u20136 discussion 146-7.","journal-title":"Neurosurgery"},{"issue":"9","key":"6569_CR23","first-page":"1188","volume":"17","author":"BM Ellingson","year":"2015","unstructured":"Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR. Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro-Oncology. 2015;17(9):1188\u201398.","journal-title":"Neuro-Oncology"},{"issue":"2","key":"6569_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.canrad.2014.10.008","volume":"19","author":"M Dor\u00e9","year":"2015","unstructured":"Dor\u00e9 M, Lefebvre L, Delpon G, Thillays F. Brain radiation necrosis after stereotactic radiotherapy of the resection cavity for intracranial metastases: analysis of the literature from four cases. Cancer Radiother. 2015;19(2):111\u20139.","journal-title":"Cancer Radiother"},{"issue":"2","key":"6569_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canrad.2013.10.013","volume":"18","author":"A Patsouris","year":"2014","unstructured":"Patsouris A, Augereau P, Tanguy JY, Morel O, Menei P, Rousseau A, Paumier A. Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis. Cancer Radiother. 2014;18(2):142\u20136.","journal-title":"Cancer Radiother"},{"issue":"6","key":"6569_CR26","first-page":"437","volume":"56","author":"DB Almeida-Freitas","year":"2014","unstructured":"Almeida-Freitas DB, Pinho MC, Otaduy MCG, Braga HF, Meira-Freitas D, da Costa Leite C. Assessment of irradiated brain metastases using dynamic contrast-enhanced magnetic resonance imaging. Neuroradiology. 2014;56(6):437\u201343.","journal-title":"Neuroradiology"},{"issue":"4","key":"6569_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00234-015-1485-9","volume":"57","author":"MJ Koh","year":"2015","unstructured":"Koh MJ, Kim HS, Choi CG, Kim SJ. Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery: focused on perfusion method. Neuroradiology. 2015;57(4):367\u201376.","journal-title":"Neuroradiology"},{"issue":"11","key":"6569_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.clon.2014.06.010","volume":"26","author":"R Jakubovic","year":"2014","unstructured":"Jakubovic R, Sahgal A, Soliman H, Milwid R, Zhang L, Eilaghi A, Aviv RI. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases. Clin Oncol (R Coll Radiol). 2014;26(11):704\u201312.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"6569_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12885-019-5413-y","volume":"19","author":"P Lesueur","year":"2019","unstructured":"Lesueur P, Lequesne J, Grellard JM, Dugu\u00e9 A, Coquan E, Brachet PE, Geffrelot J, Kao W, Emery E, Berro DH, Castera L, Goardon N, Lacroix J, Lange M, Capel A, Leconte A, Andre B, L\u00e9ger A, Lelaidier A, Clarisse B, Stefan D. Phase I\/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol. BMC Cancer. 2019;19(1):198.","journal-title":"BMC Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6569-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T02:30:43Z","timestamp":1613874643000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6569-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6569"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6569-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,22]]},"assertion":[{"value":"6 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has received ethical approval from the <i>Comit\u00e9 de Protection des Personnes Sud-est 2<\/i> in September 2018 (N\u00b0 ID-RCB: 2018-A00926\u201349) and from National Agency for Medical and Health products Safety in July 2019. All patients will give their written informed consent before any study-related assessment start.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}